HS94

CAS No. 1892594-93-2

HS94( DAPK3 inhibitor HS94 )

Catalog No. M12968 CAS No. 1892594-93-2

HS94 (DAPK3 inhibitor HS94) is a selective DAPK3 inhibitor with Ki of 126 nM, >20-fold selectivity over Pim kinases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 74 In Stock
10MG 113 In Stock
25MG 227 In Stock
50MG 330 In Stock
100MG 490 In Stock
200MG Get Quote In Stock
500MG 1051 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    HS94
  • Note
    Research use only, not for human use.
  • Brief Description
    HS94 (DAPK3 inhibitor HS94) is a selective DAPK3 inhibitor with Ki of 126 nM, >20-fold selectivity over Pim kinases.
  • Description
    HS94 (DAPK3 inhibitor HS94) is a selective DAPK3 inhibitor with Ki of 126 nM, >20-fold selectivity over Pim kinases.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    DAPK3 inhibitor HS94
  • Pathway
    Apoptosis
  • Target
    DAPK
  • Recptor
    DAPK
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1892594-93-2
  • Formula Weight
    329.378
  • Molecular Formula
    C15H15N5O2S
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    CC(C)(C(=O)N)SC1=NC2=C(C=NN2C3=CC=CC=C3)C(=O)N1
  • Chemical Name
    2-methyl-2-((4-oxo-1-phenyl-4,5-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)thio)propanamide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Carlson DA, et al. Cell Chem Biol. 2018 Jul 4. pii: S2451-9456(18)30220-4.
molnova catalog
related products
  • HS-38

    HS-38 is a potent and selective DAPK1 and DAPK3 (ZIPK) inhibitor with IC50 of 200 nM for DAPK1 and Kd of 280 nM for ZIPK.

  • HS148

    HS148 (DAPK3 inhibitor HS148) is a selective DAPK3 inhibitor with Ki of 119 nM.

  • DAPK-IN-2

    DAPK-IN-2 (WAY-380496) is a DAPK inhibitor. DAPK-IN-2 has potential anticancer activity, regulates autophagy and can be used to study cerebral infarction and ischemic diseases.